AZTR Stock Analysis: Buy, Sell, or Hold?
AZTR - Azitra Inc
$0.23
-0.01 (-3.10%)
▼
5d:
-0.64%
30d:
+23.81%
90d:
-11.44%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When AZTR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AZTR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: AZTR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: AZTR is currently trading at $0.23, which is considered slightly high relative to its 30-day fair value range of $0.16 to $0.24.
Technical Outlook: Technically, AZTR is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.38. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: AZTR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.50 (+1819.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AZTR is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.38. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: AZTR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.50 (+1819.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$0.16 -
$0.24
Company Quality Score
58/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
68.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 1819.0% below Wall St target ($4.50)
Fair Price Analysis
30-Day Fair Range
$0.16 -
$0.24
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.05
Wall Street Target
$4.50
(+1819.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 05, 2026 1:51 PM ET
Data refreshes hourly during market hours. Next update: 2:51 PM
Data refreshes hourly during market hours. Next update: 2:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AZTR showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 56 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 58 HOLD |
